B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating CAR.70, engineered IL-15-transduced cord blood-derived natural killer (NK) cells, in combination with…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for STP938 in adults with relapsed or refractory B-cell and T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma [EARLY_Phase 1]
An early-phase study evaluating a nanobody-based tandem CD19/CD20 CAR-T-cell therapy for relapsed or refractory B-cell lymphoma; the trial i…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma [Phase 1]
Phase 1 clinical trial evaluating mosunetuzumab consolidation after autologous stem cell transplantation in relapsed/refractory aggressive B…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) [Phase 3]
Phase 3 clinical trial evaluating Sonrotoclax plus Zanubrutinib versus placebo plus Zanubrutinib in adults with relapsed/refractory mantle c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma [Phase 1]
This ClinicalTrials.gov update describes an ongoing Phase 1 study of 19(T2)28z1xx TRAC-CAR T cells in patients with B-cell lymphomas, includ…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers [Phase 2]
This clinical trial update summarizes long-term safety data for pirtobrutinib in participants with previously treated blood cancers from a P…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a novel CAR T-cell therapy produced using a new technology for relapsed or refractory B-cell lymphoma …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) [Phase 1]
Phase 1 clinical trial update for MB-CART19.1 in CD19+ B-cell malignancies sponsored by Miltenyi Biomedicine GmbH. The study includes recurr…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
This is a clinical trial update for a Phase 1/2 study of BGB-16673 in combination with other agents for relapsed or refractory B-cell lympho…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This document provides a status update on a Phase 1/2 clinical trial evaluating JNJ-90014496 in participants with B-cell non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 study of NX-5948 in combination with other agents for adults with B-cell malignancies. The t…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas [Phase 1, Phase 2]
This document notes a phase 1/2 trial of an antigen-targeted T cell therapy for relapsed/refractory B-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma [Phase 2]
This document reports an ongoing Phase II trial assessing the combination of palbociclib and ibrutinib in mantle cell lymphoma, with the stu…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation [Phase 1]
This Phase 1 trial evaluated donor-derived anti-CD19 CAR-T cells in patients with recurrent or persistent B-cell malignancies after allogene…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL [Phase 3]
A Phase 3 clinical trial is planned to compare NX-5948 against Pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia and small l…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: U96-CAR-T-Cells For R/R B-ALL [Phase 1]
This clinical trial update reports a Phase 1 study of U96-CAR-T-Cells for relapsed or refractory B-cell acute lymphoblastic leukemia and B-c…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating CTX131 in adults with relapsed or refractory hematologic malignancies, assessing safety and efficacy …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies [Phase 1]
A Phase 1 study of CLIC-2201 for relapsed/refractory B-cell malignancies is currently recruiting. The conditions covered include various B-c…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating CD19/CD20 CAR/TRuC-T therapy for relapsed/refractory B-cell lymphoma, currently recruiting.
-
CLINICAL_TRIALS other · 2026-04-02Clinical Trial Update: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas [Phase 1, Phase 2]
This document provides a trial update for RN1701 Injection in Relapsed/refractory B-cell lymphoma, indicating Phase 1 and Phase 2 studies ar…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) [Phase 1]
A Phase 1 study of LY4152199 in previously treated B-cell cancers is listed, with the trial currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS other · 2026-03-19Clinical Trial Update: FT819 in Subjects With B-cell Malignancies [Phase 1]
This ClinicalTrials.gov entry provides a Phase 1 trial status update for FT819 in B-cell malignancies, indicating the study is ACTIVE_NOT_RE…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Long-term follow-up update on AvenCell-sponsored CAR-T cell trials for B-cell lymphoma and chronic lymphocytic leukemia with ongoing enrollm…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.